SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

Share Price is delayed by 15 minutes
Get Live Data
830.00    14.00 (1.72%)
Bid:
824.00
Ask:
828.00
Spread: 4.00 (0.485%)
Market Cap: £382.60m
PRV Live PriceLast checked at - London Stock Exchange

Intraday Porvair Share Chart

Acquisition and Licensing agreement

26 Sep 2013 07:00

RNS Number : 9175O
Porvair PLC
26 September 2013
 



FOR IMMEDIATE RELEASE 26 September 2013

 

 

 

Licensing agreement with Thermo Fisher Scientific

 and

Acquisition of Thomas Cain Inc

Porvair plc ("Porvair"), the specialist filtration and environmental technology group today, today announces two agreements to advance its interests in the life science and environmental laboratory markets.

A technology licensing agreement has been struck with Thermo Electron Manufacturing Ltd, a division of Thermo Fisher Scientific ("Thermo"), a global leader in scientific and laboratory supplies. Under this agreement, Porvair and Thermo will commercialise an exclusive range of life science sample preparation filters. Porvair has licensed its filter technology and will manufacture the products. Thermo will undertake sales and marketing of the filters worldwide.

 

In an unrelated agreement, Porvair has acquired the business and assets of Thomas Cain Inc, a manufacturer of environmental laboratory equipment and consumables. This small acquisition will add a complementary range of block digestion instruments and consumables to Seal's water quality analysis products. The business will be integrated into Seal Analytical's operation in Wisconsin, USA.

 

Ben Stocks, Group Chief Executive, commented:

"As part of Porvair's focus on new product development, we have been working for several years with Thermo to develop a range of laboratory sample preparation products, which we are excited to see move into the commercial phase. Porvair has received a technology transfer fee and, in addition, will generate manufacturing margins and royalties on future revenues.

 

"I am pleased to welcome the staff of Thomas Cain into the Porvair Group. Their high quality product range is highly complementary to that offered by Seal Analytical and will fit well with sales and marketing programmes already underway."

 

 

For further information, please contact:

 

Porvair plc

01553 765 500

Ben Stocks, Chief Executive

Chris Tyler, Group Finance Director

Buchanan

0207 466 5000

Charles Ryland / Helen Greenwood / Clare Akhurst

 

Notes to Editors

Porvair is a group of specialist filtration and environmental technology businesses. Its businesses design and manufacture a range of bespoke consumable filtration products that are used in a range of niche filtration markets. Its principal markets are aviation, energy and industrial process, environmental laboratories and non-ferrous metals.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBUGDCGUDBGXU
Date   Source Headline
14th Feb 201812:02 pmRNSPrice Monitoring Extension
13th Feb 20184:40 pmRNSSecond Price Monitoring Extn
13th Feb 20184:35 pmRNSPrice Monitoring Extension
1st Feb 20185:57 pmRNSBlock listing Interim Review
29th Jan 20187:00 amRNSResults for the year ended 30 November 2017
2nd Jan 201810:35 amRNSHolding(s) in Company
12th Dec 20174:52 pmRNSHolding(s) in Company
8th Dec 20177:00 amRNSPre-close Trading Update and Acquisition
6th Nov 20174:40 pmRNSSecond Price Monitoring Extn
6th Nov 20174:35 pmRNSPrice Monitoring Extension
18th Oct 20174:35 pmRNSPrice Monitoring Extension
13th Oct 201710:00 amRNSDirector's Shareholding and Issue of Equity
10th Oct 20178:27 amRNSHolding(s) in Company
3rd Oct 20174:35 pmRNSPrice Monitoring Extension
28th Sep 20177:00 amRNSAppointment of an Independent NED
19th Sep 20177:00 amRNSTrading Update
17th Aug 201711:34 amRNSHolding(s) in Company
28th Jun 201712:32 pmRNSDirector's Shareholding and Issue of Equity
27th Jun 20177:00 amRNSHalf Yearly Results
22nd Jun 201710:00 amRNSAdditional Listing
5th Jun 20177:00 amRNSTrading Update
11th Apr 201711:50 amRNSAGM resolutions
11th Apr 20177:00 amRNSAGM Statement and Trading Update
10th Apr 20174:51 pmRNSHolding(s) in Company
5th Apr 20177:00 amRNSAcquisition
24th Mar 20178:00 amRNSDirector's Shareholding and Issue of Equity
10th Mar 201712:05 pmRNSPosting of Accounts, AGM and Change of Auditor
22nd Feb 201710:33 amRNSHolding(s) in Company
30th Jan 20177:00 amRNSResults for the year ended 30 November 2016
26th Jan 20174:12 pmRNSHolding(s) in Company
6th Dec 20167:00 amRNSTrading Update and Directorate Change
30th Nov 20168:21 amRNSDirector's shareholding and changes in equity
14th Nov 201610:28 amRNSDr Krishnamurthy Rajagopal
10th Nov 20165:09 pmRNSHolding(s) in Company
3rd Oct 20164:06 pmRNSHolding(s) in Company
3rd Oct 20164:04 pmRNSHolding(s) in Company
3rd Oct 201610:29 amRNSHolding(s) in Company
21st Sep 201612:07 pmRNSSecond Price Monitoring Extn
21st Sep 201612:02 pmRNSPrice Monitoring Extension
21st Sep 20169:28 amRNSHolding(s) in Company
21st Sep 20167:00 amRNSTrading update & appointment of an Independent NED
27th Jun 20167:00 amRNSHalf yearly results
16th Jun 20163:49 pmRNSHolding(s) in Company
16th Jun 20163:48 pmRNSHolding(s) in Company
16th Jun 201611:02 amRNSHolding(s) in Company
2nd Jun 20167:00 amRNSTrading Update
17th May 20163:19 pmRNSHolding(s) in Company
17th May 20163:18 pmRNSHolding(s) in Company
12th Apr 20162:51 pmRNSAGM resolutions
18th Mar 201612:45 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.